BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-45@pharmaconomics
DTSTAMP:20260707T021607Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:SUNPH Phase 3 — Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl)\, 20% (estimated date)
DESCRIPTION:Phase 3 trial results for Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl)\, 20% in Actinic Keratosis are due ~ Jan 31\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT07144852\n\nTrack it: https://pharmaconomics.com/e/45
URL:https://pharmaconomics.com/e/45
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:SUNPH catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR